Palisade Bio
PALI
12 hedge funds and large institutions have $86.6K invested in Palisade Bio in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
20% more funds holding
Funds holding: 10 → 12 (+2)
0.03% less ownership
Funds ownership: 0.13% → 0.11% (-0.03%)
62% less capital invested
Capital invested by funds: $229K → $86.6K (-$142K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$39.7K |
| 2 |
BBA
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
|
+$12.7K |
| 3 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$12.2K |
| 4 |
OCM
Orion Capital Management
Coronado,
California
|
+$367 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$51K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$9.52K |
| 3 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$18 |
| 4 |
Wells Fargo
San Francisco,
California
|
-$18 |
PALI Hedge Fund Activity: Q3 2023 in Review
12 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q3 2023, worth a combined $86.6K — down 62% from $229K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new PALI positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 3 trimmed.
The largest buyer was Vanguard Group, adding an estimated $39.7K. The largest seller was Bank of America, exiting entirely with an estimated $51K sold.
- 12 institutional investors held Palisade Bio (PALI) as of Q3 2023, up from 10 in Q2 2023.
- Funds reported $86.6K of Palisade Bio stock for Q3 2023, down 62% quarter-over-quarter.
- 3 funds opened new Palisade Bio positions in Q3 2023 and 1 closed out, a net change of +2 holders.
- The largest Palisade Bio buyer in Q3 2023 was Vanguard Group, an estimated $39.7K added.
- The largest Palisade Bio seller in Q3 2023 was Bank of America, an estimated $51K sold.
Based on aggregated 13F filings for Q3 2023.